Works matching IS 02683369 AND DT 1997 AND VI 19 AND IP 12

Results: 17

Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1169, doi. 10.1038/sj.bmt.1700823

By:

Bertz, H;
Potthoff, K;
Mertelsmann, R;
Finke, J

Publication type:

Article

Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1233, doi. 10.1038/sj.bmt.1700813

By:

Uberti, J P;
Silver, S M;
Adams, P T;
Jacobson, P;
Scalzo, A;
Ratanatharathorn, V

Publication type:

Article

Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1197, doi. 10.1038/sj.bmt.1700792

By:

Speiser, D E;
Hermans, J;
van Biezen, A;
Starobinski, M;
Jeannet, M;
Jacobsen, N;
Niederwieser, D;
Gratwohl, A;
Apperley, J F

Publication type:

Article

Bronchiolitis obliterans organizing pneumonia after syngeneic bone marrow transplantation for acute lymphoblastic leukemia.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1251, doi. 10.1038/sj.bmt.1700816

By:

Kanda, Y;
Takahashi, T;
Imai, Y;
Miyagawa, K;
Ohishi, N;
Oka, T;
Chiba, S;
Hirai, H;
Yazaki, Y

Publication type:

Article

Transplant of bone marrow and cord blood hematopoietic stem cells in pediatric practice, revisited according to the fundamental principles of bioethics.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1163, doi. 10.1038/sj.bmt.1700825

By:

Burgio, G R;
Locatelli, F

Publication type:

Article

Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1223, doi. 10.1038/sj.bmt.1700817

By:

Schulze, R;
Schulze, M;
Wischnik, A;
Ehnle, S;
Doukas, K;
Behr, W;
Ehret, W;
Schlimok, G

Publication type:

Article

t(3;21) following peripheral blood stem cell transplantation in chronic phase chronic myeloid leukaemia.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1255, doi. 10.1038/sj.bmt.1700811

By:

Jacob, A;
Griffiths, M;
Larkins, S;
Holmes, J

Publication type:

Article

The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1239, doi. 10.1038/sj.bmt.1700812

By:

Roots-Weiß, A;
Papadimitriou, C;
Serve, H;
Hoppe, B;
Koenigsmann, M;
Reufi, B;
Oberberg, D;
Thiel, E;
Berdel, W E

Publication type:

Article

GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1175, doi. 10.1038/sj.bmt.1700814

By:

Watanabe, T;
Dave, B;
Heimann, D G;
Lethaby, E;
Kessinger, A;
Talmadge, J E

Publication type:

Article

Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome-positive CML in first chronic phase.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1205, doi. 10.1038/sj.bmt.1700824

By:

Schattenberg, A;
Preijers, F;
Mensink, E;
Bär, B;
Schaap, N;
Geurts van Kessel, A;
van der Maazen, R;
Witte, T de

Publication type:

Article

Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin’s lymphoma.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1247, doi. 10.1038/sj.bmt.1700815

By:

Snowden, J A;
Patton, W N;
O’Donnell, J L;
Hannah, E E;
Hart, D N J

Publication type:

Article

Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1261, doi. 10.1038/sj.bmt.1700826

By:

Nachbaur, D;
Kropshofer, G;
Feichtinger, H;
Allerberger, F;
Niederwieser, D

Publication type:

Article

Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1213, doi. 10.1038/sj.bmt.1700818

By:

Veena, P;
Cornetta, K;
Davidson, A;
Agüero, B;
McMahel, J;
Traycoff, C M;
Srour, E F

Publication type:

Article

Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1191, doi. 10.1038/sj.bmt.1700819

By:

Reiter, E;
Keil, F;
Brugger, S;
Kalhs, P;
Rabitsch, W;
Hinterberger, W;
Fischer, G;
Rosenmayr, A;
Haas, O;
Volc, B;
Lechner, K;
Greinix, H T

Publication type:

Article

High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1183, doi. 10.1038/sj.bmt.1700820

By:

Bensinger, W I;
Schiffman, K S;
Holmberg, L;
Appelbaum, F R;
Maziarz, R;
Montgomery, P;
Ellis, E;
Rivkin, S;
Weiden, P;
Lilleby, K;
Rowley, S;
Petersdorf, S;
Klarnet, J P;
Nichols, W;
Hertler, A;
McCroskey, R;
Weaver, C H;
Buckner, C D

Publication type:

Article

Liposomal amphotericin (AmBisome) is safe in bone marrow transplantation for primary immunodeficiency.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1229, doi. 10.1038/sj.bmt.1700821

By:

Pasic, S;
Flannagan, L;
Cant, A J

Publication type:

Article

Malaria infection after allogeneic bone marrow transplantation in a child with thalassemia.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 12, p. 1259, doi. 10.1038/sj.bmt.1700822

By:

Tran, V-B;
Lin, K-H

Publication type:

Article

Works matching IS 02683369 AND DT 1997 AND VI 19 AND IP 12

Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity.

Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies.

Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Bronchiolitis obliterans organizing pneumonia after syngeneic bone marrow transplantation for acute lymphoblastic leukemia.

Transplant of bone marrow and cord blood hematopoietic stem cells in pediatric practice, revisited according to the fundamental principles of bioethics.

Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients.

t(3;21) following peripheral blood stem cell transplantation in chronic phase chronic myeloid leukaemia.

The efficiency of tumor cell purging using immunomagnetic CD34<sup>+</sup> cell separation systems.

GM-CSF-mobilized peripheral blood CD34<sup>+</sup> cells differ from steady-state bone marrow CD34<sup>+</sup> cells in adhesion molecule expression.

Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome-positive CML in first chronic phase.

Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin’s lymphoma.

Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2.

Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34<sup>+</sup> cells.

Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.

High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.

Liposomal amphotericin (AmBisome) is safe in bone marrow transplantation for primary immunodeficiency.

Malaria infection after allogeneic bone marrow transplantation in a child with thalassemia.